WGSWW
GeneDx Holdings Corp.
NASDAQ · Healthcare · Medical - Healthcare Information Services · US
$0.00
+0.00%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-96.9%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Feb 6, 2026 | Dechairo Bryan · officer: Chief Operating Officer | Sale | 623 | $86 |
| Feb 6, 2026 | Dechairo Bryan · officer: Chief Operating Officer | Sale | 779 | $83 |
| Feb 6, 2026 | Dechairo Bryan · officer: Chief Operating Officer | Sale | 1,034 | $85 |
| Feb 6, 2026 | Dechairo Bryan · officer: Chief Operating Officer | Sale | 100 | $90 |
| Feb 6, 2026 | Dechairo Bryan · officer: Chief Operating Officer | Sale | 328 | $89 |
| Feb 6, 2026 | Dechairo Bryan · officer: Chief Operating Officer | Sale | 1,572 | $88 |
| Feb 6, 2026 | Dechairo Bryan · officer: Chief Operating Officer | Sale | 1,425 | $84 |
| Feb 3, 2026 | Dechairo Bryan · officer: Chief Operating Officer | Sale | 492 | $99 |
| Feb 3, 2026 | Dechairo Bryan · officer: Chief Operating Officer | Sale | 1,662 | $99 |
| Feb 3, 2026 | Dechairo Bryan · officer: Chief Operating Officer | M-Exempt | 9,374 | $0.00 |
| Feb 3, 2026 | Dechairo Bryan · officer: Chief Operating Officer | Sale | 1,166 | $100 |
| Feb 3, 2026 | Dechairo Bryan · officer: Chief Operating Officer | Sale | 93 | $97 |
| Feb 2, 2026 | Feeley Kevin · officer: CHIEF FINANCIAL OFFICER | Sale | 2 | $92 |
| Feb 2, 2026 | Feeley Kevin · officer: CHIEF FINANCIAL OFFICER | Sale | 315 | $94 |
| Feb 2, 2026 | Stueland Katherine · director, officer: CHIEF EXECUTIVE OFFICER | Sale | 1,653 | $94 |
| Feb 2, 2026 | Stueland Katherine · director, officer: CHIEF EXECUTIVE OFFICER | M-Exempt | 3,874 | $0.00 |
| Feb 2, 2026 | Feeley Kevin · officer: CHIEF FINANCIAL OFFICER | M-Exempt | 754 | $0.00 |
| Dec 18, 2025 | Feeley Kevin · officer: CHIEF FINANCIAL OFFICER | Sale | 26 | $151 |
| Dec 18, 2025 | Feeley Kevin · officer: CHIEF FINANCIAL OFFICER | Sale | 578 | $145 |
| Dec 18, 2025 | Feeley Kevin · officer: CHIEF FINANCIAL OFFICER | Sale | 699 | $147 |
| Dec 18, 2025 | Feeley Kevin · officer: CHIEF FINANCIAL OFFICER | Sale | 127 | $140 |
| Dec 18, 2025 | Feeley Kevin · officer: CHIEF FINANCIAL OFFICER | M-Exempt | 7,197 | $0.00 |
| Dec 18, 2025 | Feeley Kevin · officer: CHIEF FINANCIAL OFFICER | Sale | 331 | $149 |
| Dec 18, 2025 | Stueland Katherine · director, officer: CHIEF EXECUTIVE OFFICER | Sale | 369 | $139 |
| Dec 18, 2025 | Feeley Kevin · officer: CHIEF FINANCIAL OFFICER | Sale | 334 | $144 |
| Dec 18, 2025 | Feeley Kevin · officer: CHIEF FINANCIAL OFFICER | Sale | 97 | $149 |
| Dec 18, 2025 | Stueland Katherine · director, officer: CHIEF EXECUTIVE OFFICER | Sale | 940 | $144 |
| Dec 18, 2025 | Feeley Kevin · officer: CHIEF FINANCIAL OFFICER | Sale | 215 | $142 |
| Dec 18, 2025 | Stueland Katherine · director, officer: CHIEF EXECUTIVE OFFICER | Sale | 1,970 | $147 |
| Dec 18, 2025 | Feeley Kevin · officer: CHIEF FINANCIAL OFFICER | Sale | 951 | $141 |
Institutional positioning
13F filings over the trailing two quarters
New 2Increased 3Reduced 5Sold out 0
| Filer | Action | Shares | Filed |
|---|---|---|---|
| LMR PARTNERS LLP | Unchanged | 2,135,439 | May 15, 2026 |
| LMR Partners LLP | Unchanged | 2,135,439 | Aug 14, 2026 |
| D. E. Shaw & Co., Inc. | Unchanged | 467,197 | Aug 14, 2026 |
| D. E. SHAW & CO., INC. | Unchanged | 467,197 | May 15, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | Unchanged | 243,780 | May 15, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | Unchanged | 243,780 | Aug 14, 2026 |
| MILLENNIUM MANAGEMENT LLC | Unchanged | 214,106 | Aug 14, 2026 |
| MILLENNIUM MANAGEMENT LLC | Unchanged | 214,106 | May 15, 2026 |
| Q GLOBAL ADVISORS, LLC | Unchanged | 111,701 | May 15, 2026 |
| Q Global Advisors, LLC | Unchanged | 111,701 | Aug 14, 2026 |
| TORONTO DOMINION BANK | Reduced | 105,950 | May 15, 2026 |
| TORONTO DOMINION BANK | Reduced | 105,050 | Aug 14, 2026 |
| StoneX Group Inc. | Increased | 97,188 | Aug 12, 2026 |
| Virtu Financial LLC | New Position | 73,345 | Aug 13, 2026 |
| WOLVERINE ASSET MANAGEMENT LLC | Increased | 60,320 | Aug 10, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Feb 6, 2026